Q3 2023 Jubilant Pharmova Ltd Earnings Call Transcript
Good evening, ladies and gentlemen, and welcome to the Jubilant Pharmova Limited Q3 and 9 Months FY '23 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Vineet Mayer, Investor Relations and Corporate Finance, Jubilant Pharmova Limited. Thank you, and over to you, sir.
Thank you, Indira. Good evening, everyone. Thank you for being with us on our Q3 and 9-month FY '23 Earnings Conference Call.
I would like to remind you that some of the statements made on the call today could be forward-looking in nature and a detailed disclaimer in this regard has been included in the Press Release that has been shared on our website. On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. Arvind Chokhany, Group CFO; Mr. Arun Sharma, CFO of Jubilant Pharmova; Mr. Pramod Yadav, CEO of Specialty Pharma and CDMO of Sterile Injectables business, Dr. Jaidev Rajpal,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |